Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Permeability and Microbiome in Very Low Birth Weight Preterm Neonates
NCT07667049Phase 1Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lactulose + rhamnose in Prematurity (PTB), sponsored by University of Maryland, Baltimore. Primary endpoint: Measurement of intestinal permeability at 1 year. Started Sep 2026; status: recruiting.
02
Drugs
lactulose + rhamnose
03
Conditions
Prematurity (PTB)
Beyond the preview
Go deeper on NCT07667049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667049.